Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Cholangiocarcinoma and CDKN2A[original query] |
|---|
| Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PloS one 2014 9 (12): e115383. Churi Chaitanya R, Shroff Rachna, Wang Ying, Rashid Asif, Kang HyunSeon C, Weatherly Jacqueline, Zuo Mingxin, Zinner Ralph, Hong David, Meric-Bernstam Funda, Janku Filip, Crane Christopher H, Mishra Lopa, Vauthey Jean-Nicholas, Wolff Robert A, Mills Gordon, Javle Mili |
| Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations. Oncotarget 2016 Mar . Kim Young-Ho, Hong Eun-Kyung, Kong Sun-Young, Han Sung-Sik, Kim Seoung-Hoon, Rhee Je-Keun, Hwang Soo-Kyung, Park Sang-Jae, Kim Tae-M |
| Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine. JCO precision oncology 2020 9 3 . Mondaca Sebastian, Razavi Pedram, Xu Chongrui, Offin Michael, Myers Mackenzie, Scaltriti Maurizio, Hechtman Jaclyn F, Bradley Mikaela, O'Reilly Eileen M, Berger Michael F, Solit David B, Li Bob T, Abou-Alfa Ghassan |
| Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients. JCO precision oncology 2020 4 . Cao Jingyu, Hu Jing, Liu Siqin, Meric-Bernstam Funda, Abdel-Wahab Reham, Xu Junjie, Li Qiang, Yan Maolin, Feng Yujie, Lin Jianzhen, Zhao Songhui, Wang Jian, Kwong Lawrence N, Hu Jinwei, Carapeto Fernando, Borad Mitesh J, Wang Kai, Javle Milind, Zhao Hait |
| Characteristics of genomic alterations in Chinese cholangiocarcinoma patients. Japanese journal of clinical oncology 2020 Jun . Jiang Guoping, Zhang Wu, Wang Ting, Ding Songming, Shi Xiaoliang, Zhang Shuirong, Shi Weiwei, Liu Angen, Zheng Shus |
| Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies. Frontiers in oncology 2020 5 10 536. Wang Shuhang, Chen Rongrong, Tang Yu, Yu Yue, Fang Yuan, Huang Huiyao, Wu Dawei, Fang Hong, Bai Ying, Sun Chao, Yu Anqi, Fan Qi, Gu Dejian, Yi Xin, Li Ni |
| Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities. Hepatology (Baltimore, Md.) 2020 Jan . Goeppert Benjamin, Folseraas Trine, Roessler Stephanie, Kloor Matthias, Volckmar Anna-Lena, Endris Volker, Buchhalter Ivo, Stenzinger Albrecht, Grzyb Krzysztof, Grimsrud Marit M, Gornicka Barbara, von Seth Erik, Reynolds Gary M, Franke Andre, Gotthardt Daniel N, Mehrabi Arianeb, Cheung Angela, Verheij Joanne, Arola Johanna, Mäkisalo Heikki, Eide Tor J, Weidemann Sören, Cheville John C, Mazza Giuseppe, Hirschfield Gideon M, Ponsioen Cyriel Y, Bergquist Annika, Milkiewicz Piotr, Lazaridis Konstantinos N, Schramm Christoph, Manns Michael P, Färkkilä Martti, Vogel Arndt, , Boberg Kirsten M, Schirmacher Peter, Karlsen Tom |
| Actionability evaluation of biliary tract cancer by genome transcriptome analysis and Asian cancer knowledgebase. Oncotarget 2021 Jul 12 (15): 1540-1552. Okawa Yuki, Ebata Nobutaka, Kim Nayoung K D, Fujita Masashi, Maejima Kazuhiro, Sasagawa Shota, Nakamura Toru, Park Woong-Yang, Hirano Satoshi, Nakagawa Hidewa |
| Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 5 27 (14): 4101-4108. Jolissaint Joshua S, Soares Kevin C, Seier Kenneth P, Kundra Ritika, Gönen Mithat, Shin Paul J, Boerner Thomas, Sigel Carlie, Madupuri Ramyasree, Vakiani Efsevia, Cercek Andrea, Harding James J, Kemeny Nancy E, Connell Louise C, Balachandran Vinod P, D'Angelica Michael I, Drebin Jeffrey A, Kingham T Peter, Wei Alice C, Jarnagin William |
| Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma. Hepatology (Baltimore, Md.) 2021 3 74 (3): 1429-1444. Boerner Thomas, Drill Esther, Pak Linda M, Nguyen Bastien, Sigel Carlie S, Doussot Alexandre, Shin Paul, Goldman Debra A, Gonen Mithat, Allen Peter J, Balachandran Vinod P, Cercek Andrea, Harding James, Solit David B, Schultz Nikolaus, Kundra Ritika, Walch Henry, D'Angelica Michael I, DeMatteo Ronald P, Drebin Jeffrey, Kemeny Nancy E, Kingham T Peter, Simpson Amber L, Hechtman Jaclyn F, Vakiani Efsevia, Lowery Maeve A, Ijzermans J N M, Buettner S, Koerkamp B Groot, Doukas M, Chandwani Rohit, Jarnagin William |
| Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 2021 3 11 (10): 4585-4598. Lin Jianzhen, Cao Yinghao, Yang Xu, Li Guangyu, Shi Yang, Wang Dongxu, Long Junyu, Song Yang, Mao Jinzhu, Xie Fucun, Bai Yi, Zhang Lei, Yang Xiaobo, Wan Xueshuai, Wang Anqiang, Guan Mei, Zhao Lin, Hu Ke, Pan Jie, Huo Li, Lu Xin, Mao Yilei, Sang Xinting, Zhang Henghui, Wang Kai, Wang Xiaoyue, Zhao Hait |
| Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study. Frontiers in oncology 2022 9 12 988527. Takada Kohichi, Kubo Tomohiro, Kikuchi Junko, Yoshida Makoto, Murota Ayako, Arihara Yohei, Nakamura Hajime, Nagashima Hiroyuki, Tanabe Hiroki, Sugita Shintaro, Tanaka Yumi, Miura Ayana, Ohhara Yoshihito, Ishiguro Atsushi, Yokouchi Hiroshi, Kawamoto Yasuyuki, Mizukami Yusuke, Ohnishi Hirofumi, Kinoshita Ichiro, Sakurai Akihi |
| Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis. Targeted oncology 2022 Sep 17 (5): 591-596. Rimini Margherita, Burgio Valentina, Antonuzzo Lorenzo, Rimassa Lorenza, Oneda Ester, Lavacchi Daniele, Personeni Nicola, Ratti Francesca, Pedica Federica, Della Corte Angelo, Persano Mara, De Cobelli Francesco, Aldrighetti Luca, Scartozzi Mario, Cascinu Stefano, Casadei-Gardini Andr |
| Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis. The Journal of pathology 2022 Jul . Kamp Eline Jca, Dinjens Winand Nm, Doukas Michail, van Marion Ronald, Verheij Joanne, Ponsioen Cyriel Y, Bruno Marco J, Groot Koerkamp Bas, Trivedi Palak J, Peppelenbosch Maikel P, de Vries Annemarie |
| Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
| Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
| Platinum sensitivity in patients with IDH1/2 mutated versus wild-type intrahepatic cholangiocarcinoma: a propensity score-based study. International journal of cancer 2022 Jun . Niger Monica, Nichetti Federico, Casadei-Gardini Andrea, Rizzato Mario Domenico, Pircher Chiara, Bini Marta, Franza Andrea, Rimini Margherita, Burgio Valentina, Sposetti Caterina, Fornaro Lorenzo, Rapposelli Ilario Giovanni, D'Amico Francesco Enrico, Aprile Giuseppe, Vivaldi Caterina, Frassineti Giovanni Luca, Milione Massimo, Leoncini Giuseppe, Cappetta Alessandro, Vasile Enrico, Fassan Matteo, Morano Federica, Perrone Federica, Tamborini Elena, Pruneri Giancarlo, Lonardi Sara, Mazzaferro Vincenzo, Pietrantonio Filippo, Di Bartolomeo Maria, de Braud Filip |
| Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience. Therapeutic advances in medical oncology 2023 7 15 17588359231171574. Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardi |
| Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. Nature communications 2023 2 14 (1): 630. Harding James J, Piha-Paul Sarina A, Shah Ronak H, Murphy Jessica J, Cleary James M, Shapiro Geoffrey I, Quinn David I, Braña Irene, Moreno Victor, Borad Mitesh, Loi Sherene, Spanggaard Iben, Park Haeseong, Ford James M, Arnedos Mónica, Stemmer Salomon M, de la Fouchardiere Christelle, Fountzilas Christos, Zhang Jie, DiPrimeo Daniel, Savin Casey, Duygu Selcuklu S, Berger Michael F, Eli Lisa D, Meric-Bernstam Funda, Jhaveri Komal, Solit David B, Abou-Alfa Ghassan |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: